Literature DB >> 30304676

Relationship between PIWIL4-Mediated H3K4me2 Demethylation and piRNA-Dependent DNA Methylation.

Ippei Nagamori1, Hisato Kobayashi2, Toru Nishimura3, Reina Yamagishi3, Jun Katahira4, Satomi Kuramochi-Miyagawa5, Tomohiro Kono6, Toru Nakano7.   

Abstract

Retrotransposon genes are silenced by DNA methylation because of potential harm due to insertional mutagenesis. DNA methylation of retrotransposon genes is erased and re-established during male germ cell development. Both piRNA-dependent and piRNA-independent mechanisms are active during the re-establishment process, with the piRNA-independent mechanism occurring first. In this study, we analyzed the role of PIWIL4/MIWI2 in the modification of histone H3 and subsequent piRNA-dependent DNA methylation. Dimethylation at H3K4 is highly enriched at piRNA-dependent methylated regions and anti-correlated with de novo DNA methylation during the phase of piRNA-independent DNA methylation. In addition, PIWIL4, which binds the H3K4 demethylases KDM1A and KDM5B, is required for removing H3K4me2 marks. These data show that PIWIL4 plays important roles in histone modification and piRNA-dependent DNA methylation.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; germ cell; gonocyte; piRNA; spermatogenesis

Year:  2018        PMID: 30304676     DOI: 10.1016/j.celrep.2018.09.017

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  8 in total

1.  Association between H3K36me3 modification and methylation of LINE-1 and MGMT in peripheral blood lymphocytes of PAH-exposed workers.

Authors:  Xiumei Xing; Zhini He; Ziwei Wang; Ziying Mo; Liping Chen; Boyi Yang; Zhengbao Zhang; Shen Chen; Lizhu Ye; Rui Zhang; Yuxin Zheng; Wen Chen; Daochuan Li
Journal:  Toxicol Res (Camb)       Date:  2020-10-01       Impact factor: 3.524

Review 2.  RNA matchmaking in chromatin regulation.

Authors:  Stephen K Wu; Justin T Roberts; Maggie M Balas; Aaron M Johnson
Journal:  Biochem Soc Trans       Date:  2020-12-18       Impact factor: 5.407

3.  Cell-fate transition and determination analysis of mouse male germ cells throughout development.

Authors:  Jiexiang Zhao; Ping Lu; Cong Wan; Yaping Huang; Gang Chang; Manman Cui; Xinyan Yang; Yuqiong Hu; Yi Zheng; Ji Dong; Mei Wang; Shu Zhang; Zhaoting Liu; Shuhui Bian; Xiaoman Wang; Rui Wang; Shaofang Ren; Dazhuang Wang; Zhaokai Yao; Fuchou Tang; Xiao-Yang Zhao
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

4.  MORC3, a novel MIWI2 association partner, as an epigenetic regulator of piRNA dependent transposon silencing in male germ cells.

Authors:  Kanako Kojima-Kita; Satomi Kuramochi-Miyagawa; Manabu Nakayama; Haruhiko Miyata; Steven E Jacobsen; Masahito Ikawa; Haruhiko Koseki; Toru Nakano
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

5.  piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.

Authors:  Qi Xie; Zhen Li; Xiao Luo; Dan Wang; Yao Zhou; Jingge Zhao; Suhua Gao; Yongguang Yang; Wanying Fu; Lingfei Kong; Tingyi Sun
Journal:  J Transl Med       Date:  2022-01-29       Impact factor: 5.531

6.  Disruption of piRNA machinery by deletion of ASZ1/GASZ results in the expression of aberrant chimeric transcripts in gonocytes.

Authors:  Shinya Ikeda; Koki Tanaka; Reiko Ohtani; Akifumi Kanda; Yusuke Sotomaru; Tomohiro Kono; Yayoi Obata
Journal:  J Reprod Dev       Date:  2022-01-30       Impact factor: 2.214

Review 7.  PIWI-interacting RNAs: Mitochondria-based biogenesis and functions in cancer.

Authors:  Jing-Fen Su; Anthony Concilla; Dian-Zheng Zhang; Fang Zhao; Fang-Fang Shen; Hao Zhang; Fu-You Zhou
Journal:  Genes Dis       Date:  2020-10-05

Review 8.  Piwi-interacting RNAs (piRNAs) as potential biomarkers and therapeutic targets for cardiovascular diseases.

Authors:  Min Li; Yanyan Yang; Zhibin Wang; Tingyu Zong; Xiuxiu Fu; Lynn Htet Htet Aung; Kun Wang; Jian-Xun Wang; Tao Yu
Journal:  Angiogenesis       Date:  2020-10-04       Impact factor: 10.658

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.